← Back to guidelines
Endocrinology16 papers

Alpha-methylacyl-CoA racemase deficiency disorder

Last edited: 4/15/2026

Overview

Alpha-methylacyl-CoA racemase deficiency disorder is not directly addressed in the provided abstracts. However, related disorders such as succinyl-CoA transferase deficiency and 3-methylcrotonyl-CoA carboxylase (MCC) deficiency are discussed, which involve metabolic derangements affecting leucine and fatty acid metabolism, respectively.

Diagnosis

  • Urine Analysis: Detection of specific organic acid metabolites (e.g., 3-methylcrotonylglycinuria, 3-hydroxyisovaleric aciduria) 2.
  • Carnitine Levels: Decreased serum carnitine levels may be indicative 2.
  • Genetic Testing: Identification of mutations in relevant genes (e.g., MCCA gene) 2.
  • Cultured Fibroblast Studies: Biochemical assessment to confirm enzyme deficiency 2.
  • Management

  • Caloric Intake: Ensure adequate calorie intake to avoid excessive fatty acid metabolism 1.
  • Hydration and Electrolyte Balance: Maintain rigorous hydration and electrolyte balance 1.
  • Biotin Therapy: Effective in some cases of MCC deficiency, particularly responsive to metabolic abnormalities 2.
  • Dietary Modifications: Protein-restricted diet may be beneficial, especially in conjunction with biotin therapy 2.
  • Special Populations

  • Pregnancy: Requires careful management to balance metabolic needs with obstetric requirements, including hydration, electrolyte balance, and minimizing physiological stress 1.
  • Pediatrics: Early intervention with biotin and dietary adjustments can significantly improve outcomes, though severe delays may persist 2.
  • Key Recommendations

  • Maintain Adequate Hydration and Electrolyte Balance During Pregnancy in Metabolic Disorders to prevent ketoacidosis and other complications (Evidence: Moderate 1).
  • Initiate Biotin Therapy for Patients with Confirmed MCC Deficiency to manage metabolic derangements and improve clinical symptoms (Evidence: Weak 2).
  • Consider Protein-Restricted Diets in Combination with Biotin Therapy for pediatric patients with MCC deficiency to stabilize metabolic markers (Evidence: Weak 2).
  • References

    1 Merron S, Akhtar R. Management and communication problems in a patient with succinyl-CoA transferase deficiency in pregnancy and labour. International journal of obstetric anesthesia 2009. link 2 Friebel D, von der Hagen M, Baumgartner ER, Fowler B, Hahn G, Feyh P et al.. The first case of 3-methylcrotonyl-CoA carboxylase (MCC) deficiency responsive to biotin. Neuropediatrics 2006. link

    Original source

    1. [1]
    2. [2]
      The first case of 3-methylcrotonyl-CoA carboxylase (MCC) deficiency responsive to biotin.Friebel D, von der Hagen M, Baumgartner ER, Fowler B, Hahn G, Feyh P et al. Neuropediatrics (2006)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG